Abstract

BackgroundSynthesis of patient-reported outcome (PRO) data is hindered by the range of available PRO measures (PROMs) composed of multiple scales and single items with differing terminology and content. The use of core outcome sets, an agreed minimum set of outcomes to be measured and reported in all trials of a specific condition, may improve this issue but methods to select core PRO domains from the many available PROMs are lacking. This study examines existing PROMs and describes methods to identify health domains to inform the development of a core outcome set, illustrated with an example.MethodsSystematic literature searches identified validated PROMs from studies evaluating radical treatment for oesophageal cancer. PROM scale/single item names were recorded verbatim and the frequency of similar names/scales documented. PROM contents (scale components/single items) were examined for conceptual meaning by an expert clinician and methodologist and categorised into health domains. A patient advocate independently checked this categorisation.ResultsSearches identified 21 generic and disease-specific PROMs containing 116 scales and 32 single items with 94 different verbatim names. Identical names for scales were repeatedly used (for example, ‘physical function’ in six different measures) and others were similar (overlapping face validity) although component items were not always comparable. Based on methodological, clinical and patient expertise, 606 individual items were categorised into 32 health domains.ConclusionThis study outlines a methodology for identifying candidate PRO domains from existing PROMs to inform a core outcome set to use in clinical trials.

Highlights

  • Synthesis of patient-reported outcome (PRO) data is hindered by the range of available patient reported outcomes (PROs) measures (PROMs) composed of multiple scales and single items with differing terminology and content

  • Identification of Patient reported outcome measure (PROM) used in oesophageal cancer studies A total of 1,351 records were screened for inclusion and 111 full-text articles were assessed for eligibility

  • Our findings show how evidence synthesis of oesophageal cancer PROs may be hampered because of the range of PROMs used in trials and the multiple scales and single items within them, often with inconsistent and nontransparent terminology

Read more

Summary

Introduction

Synthesis of patient-reported outcome (PRO) data is hindered by the range of available PRO measures (PROMs) composed of multiple scales and single items with differing terminology and content. Problems are further accentuated for PROs because terminology of the scales and items across PROMs is not universally agreed meaning data synthesis across studies is difficult when different questionnaires are used, and while there is overlap in the issues that are measured there is variation because PROMs have been developed by different methods and for different purposes. Potential solutions to these challenges are to develop and use core outcome sets

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call